$PSID As a developer of biological detection and diagnostics solutions, PositiveID Corp. (OTCQB: PSID) is in a very large and rapidly growing market niche. The biosensor industry reached $12.46B in 2013 alone, with a 14.19% compounded annual growth rate (CAGR) forecast between the years 2013-2018. After the calculations are made, this would mean that by 2018, the biosensor industry could be worth $24.19B, which would be nearly double the existing industry size. With explosive growth like this, the potential for individual company growth is astounding. One of the leading factors helping to produce such impressive growth rates is the publicity being brought to bioterrorism, virus outbreaks, and general development of chemical/biological weaponry in unstable countries.
$PSID As a developer of biological detection and
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Super Hi Reports Strong Q2 2024 Financial Results
Super Hi Reports Impressive Q2 2024 Financial Results Super Hi International Holding Ltd. (NASDAQ: HDL and HKEX: 9658), a prominent brand in Chinese cuisine known for its Haidilao hot pot restaurants worldwide, has announced its unaudited financial results for the second quarter of FY2024, which ended on June 30, 2024. Financial Highlights for Q2 2024 The company's...
Continue Reading
BEN Expands AI Reach with $1M Accelevate Stake
A Strategic Move with a Million-Dollar Stake What do you call a million bucks invested in a company called Accelevate? Well, Brand Engagement Network, Inc. (NASDAQ: BNAI) seems to think it's just good business sense. They've tossed a cool million at Accelevate Solutions, snagging themselves about 10% ownership straight off the bat. Let me tell you, when folks throw around...
Continue Reading
Vasa Therapeutics Accelerates Heart Failure Treatment with VS-041
Vasa Therapeutics Receives FDA Fast Track Designation for VS-041 Vasa Therapeutics, a biopharmaceutical company focused on innovative therapies for cardiovascular issues, is making significant strides with its lead investigational drug, VS-041. Recently, the FDA granted Fast Track designation for this unique treatment aimed at addressing heart failure with preserved...
Continue Reading
Legal Action Launched for Acadia Healthcare Investors Amid Concerns
Introduction to the Class Action Lawsuit The Law Offices of Frank R. Cruz has initiated a class action lawsuit on behalf of investors of Acadia Healthcare Company Inc. (NASDAQ: ACHC). This legal motion concerns individuals and entities who purchased or acquired Acadia securities during a specified period. The lawsuit is rooted in serious allegations regarding the...
Continue Reading
Linux Foundation Launches Akrites for Open Source Security
The Battle Against AI-Driven Vulnerabilities Alright, let's dive into this. These days, open source software is the backbone holding up pretty much every industry out there. Banking, healthcare, energy—you name it, it's running on it. But here's the kicker: AI's making it a heck of a lot easier for the bad guys to find holes in it. The Linux Foundation just christened...
Continue Reading